SkinHealth Systems Inc. (SKIN) stock
SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30316% above fair value
$12.46−1.41 (-10.20%)
Close on Nov 18, 2026Market cap $1.62BP/E –Yield –
SkinHealth Systems operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
SkinHealth Systems's operating income for the twelve months ending Jun 30, 2026 was -$4.31M. For fiscal 2025 it was -$20.80M. The highest annual figure on record is $13.46M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$20.80M | – |
| FY2024 | Dec 31, 2024 | -$67.77M | – |
| FY2023 | Dec 31, 2023 | -$130.92M | – |
| FY2022 | Dec 31, 2022 | -$25.84M | – |
| FY2021 | Dec 31, 2021 | -$39.93M | – |
| FY2020 | Dec 31, 2020 | -$17.18M | -227.6% |
| FY2019 | Dec 31, 2019 | $13.46M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.57M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.80M | – |
| Q4 FY2025 | Dec 31, 2025 | $162.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.24M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.70M | – |
| Q1 FY2025 | Mar 31, 2025 | -$12.02M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.16M | – |
| Q3 FY2024 | Sep 30, 2024 | -$21.52M | – |
| Q2 FY2024 | Jun 30, 2024 | -$22.11M | – |
| Q1 FY2024 | Mar 31, 2024 | -$16.99M | – |
| Q4 FY2023 | Dec 31, 2023 | -$18.36M | – |
| Q3 FY2023 | Sep 30, 2023 | -$82.10M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.15M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.31M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.45M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.35M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.03M | – |
| Q1 FY2022 | Mar 31, 2022 | -$14.01M | -688.3% |
| Q4 FY2021 | Dec 31, 2021 | -$10.50M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.46M | -295.9% |
| Q2 FY2021 | Jun 30, 2021 | -$26.35M | – |
| Q1 FY2021 | Mar 31, 2021 | $2.38M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.71M | – |
| Q3 FY2020 | Sep 30, 2020 | $2.79M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.92M | – |
See a number that looks wrong?